Skip to content

Petrovax

A company of novel biopharmaceutical practices.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Petrovax is a biopharmaceutical company founded in 1996 by a team of Russian scientists. Its development strategy focuses on providing patients with in-demand vaccines and biotech drugs for the prevention and treatment of infectious, orphan, and oncological diseases. The product portfolio includes original pharmaceutical products, contract medicines and food supplements. The company has modern biotechnological production in accordance with the EAEU and EU GMP standards and is one of the largest exporters of original pharmaceutical products and vaccines for the prevention of influenza. It partners with international Big Pharma companies such as Pfizer, Abbott, Boehringer Ingelheim, and ISU ABXIS.

History

The company was founded in 1996 by a team of Russian scientists. Localized full-cycle production of the immuno-oncology medicine Areima® launched in Russia. Obtaining a license from the Russian Ministry of Industry and Trade to manufacture a vaccine against meningococcal infection. Polyoxidonium® has been included in a new standard of medical care for adults with influenza and in new recommendations for the treatment of ARVI in children. Signing a cooperation agreement with the Union of Pediatricians of Russia to develop a culture of vaccination. Signing a cooperation agreement with the Presidential Academy (RANEPA) to assess...

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/petrovax · Editorial policy · How profiles are compiled